Vascular Effects of Sertraline in Heart Failure
NCT00585455 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 4
Last updated 2009-07-23
Summary
To determine the effects of chronic sertraline treatment on brachial artery flow-mediated dilation in patients with chronic heart failure and depression
Conditions
Interventions
- DRUG
-
sertraline
open label 25-50 mg daily as tolerated
Sponsors & Collaborators
- collaborator INDUSTRY
-
Yale University
lead OTHER
Principal Investigators
-
Stuart Katz, MD · Yale University
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-01-31
- Primary Completion
- 2009-07-31
- Completion
- 2009-07-31
Countries
- United States
Study Locations
More Related Trials
-
Chronic Kidney Disease Antidepressant Sertraline Trial
NCT00946998 ·Status: COMPLETED ·Phase: PHASE3
-
Special Investigation Of Long Term Use Of Sertraline.
NCT00605813 ·Status: COMPLETED
-
Predicting SSRI Efficacy in Veterans With PTSD
NCT04183205 ·Status: TERMINATED ·Phase: PHASE4
-
Treatment Outcome of Vascular Depression
NCT00045773 ·Status: COMPLETED
-
Study to Evaluate The Effect Of Sertraline on the Cardiac Repolarization in Healthy Subjects
NCT02651623 ·Status: COMPLETED ·Phase: PHASE1
-
Maintenance Study for Adolescent Depression
NCT00508859 ·Status: COMPLETED ·Phase: PHASE4
-
Sertraline and Cognitive Therapy in Depressed Alcoholics
NCT00000458 ·Status: COMPLETED ·Phase: PHASE2
-
Drug Use Investigation of Jzoloft.
NCT00605865 ·Status: COMPLETED
-
Combination Therapy in Patients With Depression
NCT00485862 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluating the Effectiveness of Sertraline in Treating Women With Premenstrual Dysphoric Disorder
NCT00536198 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Citalopram on Hostility and CHD Risk
NCT00217828 ·Status: COMPLETED ·Phase: NA
-
Antidepressant Treatment for Premenstrual Syndrome and Premenstrual Dysphoric Disorder
NCT00048854 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Acute Myocardial Necrosis and Depression: Antiplatelet Effect of Reuptake Inhibition of Serotonin
NCT02463110 ·Status: TERMINATED ·Phase: PHASE4
-
The Influence of the Menstrual Cycle on Lithium and Sertraline Blood Levels
NCT01385709 ·Status: COMPLETED
-
Assessment of the Effect of Sertaline on the Specific Binding of 123-I MZINT in Healthy Subjects
NCT00470925 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of Stress Disorders
NCT00050804 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Sertraline on Inflammation in Hemodialysis Patients with Depression: a Randomized Controlled Trial
NCT06840379 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
The Effectiveness of Sertraline in Patients Who Have Had Inadequate Response to Escitalopram
NCT00179257 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Sertraline in the Treatment of Maintenance Hemodialysis Patients With Depression
NCT06124417 ·Status: COMPLETED ·Phase: PHASE4
-
Selenium as Augmentation Treatment for Sertraline Resistant Major Depression
NCT02890212 ·Status: SUSPENDED ·Phase: NA
-
Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania
NCT00118014 ·Status: COMPLETED ·Phase: PHASE4
-
Personalized Sertraline Dosing in Patients With Depression
NCT05210153 ·Status: WITHDRAWN
-
The Effect of Agomelatine or Fluoxentine on Heart Rate Variability in Patients With Major Depressive Disorder
NCT00451490 ·Status: WITHDRAWN ·Phase: NA
-
Chinese Herb for the Treatment of Depression and Anxiety Disorders
NCT03323697 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Repetitive Behavior Disorders in People With Severe Mental Retardation
NCT00491478 ·Status: UNKNOWN ·Phase: PHASE3